Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Neuroscience Neurotransmission Receptors / Channels Sodium Channels

Anti-Nav1.5/SCN5A antibody (ab86321)

Anti-Nav1.5/SCN5A antibody (ab86321)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to Nav1.5/SCN5A
  • Suitable for: WB
  • Reacts with: Rat, Human
  • Isotype: IgG

You may also be interested in

Product image
Human SCN1B knockout HeLa cell line (ab264733)
Anti-Nav1.6/SCN8A antibody (ab65166)
Product image
Anti-pan Sodium Channel antibody (ab53724)
Recombinant Human ASIC3 protein (ab126012)

Overview

  • Product name

    Anti-Nav1.5/SCN5A antibody
    See all Nav1.5/SCN5A primary antibodies
  • Description

    Rabbit polyclonal to Nav1.5/SCN5A
  • Host species

    Rabbit
  • Tested Applications & Species

    Application Species
    WB
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide corresponding to Human Nav1.5/SCN5A aa 1-100 conjugated to keyhole limpet haemocyanin.
    (Peptide available as ab96114)

  • Positive control

    • This antibody gave a positive signal in both Human and Rat heart tissue lysate.
  • General notes

     This product was previously labelled as Nav1.5

     

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.40
    Preservative: 0.02% Sodium azide
    Constituent: PBS

    Batches of this product that have a concentration
  • Concentration information loading...
  • Purity

    Immunogen affinity purified
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Neuroscience
    • Neurotransmission
    • Receptors / Channels
    • Sodium Channels
    • Cardiovascular
    • Heart
    • Cardiac arrhythmias

Associated products

  • Compatible Secondaries

    • Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077)
    • Goat Anti-Rabbit IgG H&L (HRP) (ab205718)
  • Isotype control

    • Rabbit IgG, polyclonal - Isotype Control (ChIP Grade) (ab171870)
  • Recombinant Protein

    • Recombinant Human Nav1.5/SCN5A protein (ab132328)

Applications

The Abpromise guarantee

Our Abpromise guarantee covers the use of ab86321 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Guaranteed

Tested applications are guaranteed to work and covered by our Abpromise guarantee.

Predicted

Predicted to work for this combination of applications and species but not guaranteed.

Incompatible

Does not work for this combination of applications and species.

Application Species
WB
Human
Application Abreviews Notes
WB
Use a concentration of 1 µg/ml. Detects a band of approximately 248 kDa (predicted molecular weight: 227 kDa).
Notes
WB
Use a concentration of 1 µg/ml. Detects a band of approximately 248 kDa (predicted molecular weight: 227 kDa).

Target

  • Function

    This protein mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient. It is a tetrodotoxin-resistant Na(+) channel isoform. This channel is responsible for the initial upstroke of the action potential.
  • Tissue specificity

    Found in jejunal circular smooth muscle cells (at protein level). Expressed in human atrial and ventricular cardiac muscle but not in adult skeletal muscle, brain, myometrium, liver, or spleen. Isoform 4 is expressed in brain.
  • Involvement in disease

    Defects in SCN5A are a cause of progressive familial heart block type 1A (PFHB1A) [MIM:113900]; also known as Lenegre-Lev disease or progressive cardiac conduction defect (PCCD). PFHB1A is an autosomal dominant cardiac bundle branch disorder that may progress to complete heart block. PFHB1A is characterized by progressive alteration of cardiac conduction through the His-Purkinje system with right or left bundle branch block and widening of QRS complexes, leading to complete atrio-ventricular block and causing syncope and sudden death.
    Defects in SCN5A are the cause of long QT syndrome type 3 (LQT3) [MIM:603830]. Long QT syndromes are heart disorders characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress. LQT3 inheritance is an autosomal dominant.
    Defects in SCN5A are the cause of Brugada syndrome type 1 (BRS1) [MIM:601144]. BRS1 is an autosomal dominant tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs (called ventricular fibrillation), the individual will faint and may die in a few minutes if the heart is not reset.
    Defects in SCN5A are the cause of sick sinus syndrome type 1 (SSS1) [MIM:608567]. The term 'sick sinus syndrome' encompasses a variety of conditions caused by sinus node dysfunction. The most common clinical manifestations are syncope, presyncope, dizziness, and fatigue. Electrocardiogram typically shows sinus bradycardia, sinus arrest, and/or sinoatrial block. Episodes of atrial tachycardias coexisting with sinus bradycardia ('tachycardia-bradycardia syndrome') are also common in this disorder. SSS occurs most often in the elderly associated with underlying heart disease or previous cardiac surgery, but can also occur in the fetus, infant, or child without heart disease or other contributing factors, in which case it is considered to be a congenital disorder.
    Defects in SCN5A are the cause of ventricular fibrillation paroxysmal familial type 1 (VF1) [MIM:603829]. A cardiac arrhythmia marked by fibrillary contractions of the ventricular muscle due to rapid repetitive excitation of myocardial fibers without coordinated contraction of the ventricle and by absence of atrial activity.
    Defects in SCN5A can be a cause of sudden infant death syndrome (SIDS) [MIM:272120]. SIDS is the sudden death of an infant younger than 1 year that remains unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of clinical history. Pathophysiologic mechanisms for SIDS may include respiratory dysfunction, cardiac dysrhythmias, cardiorespiratory instability, and inborn errors of metabolism, but definitive pathogenic mechanisms precipitating an infant sudden death remain elusive. Long QT syndromes-associated mutations can be responsible for some of SIDS cases.
    Defects in SCN5A may be a cause of familial atrial standstill (FAS) [MIM:108770]. Atrial standstill is an extremely rare arrhythmia, characterized by the absence of electrical and mechanical activity in the atria. Electrocardiographically, it is characterized by bradycardia, the absence of P waves, and a junctional narrow complex escape rhythm.
    Defects in SCN5A are the cause of cardiomyopathy dilated type 1E (CMD1E) [MIM:601154]; also known as dilated cardiomyopathy with conduction disorder and arrhythmia or dilated cardiomyopathy with conduction defect 2. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
  • Sequence similarities

    Belongs to the sodium channel (TC 1.A.1.10) family. Nav1.5/SCN5A subfamily.
    Contains 1 IQ domain.
  • Domain

    The sequence contains 4 internal repeats, each with 5 hydrophobic segments (S1,S2,S3,S5,S6) and one positively charged segment (S4). Segments S4 are probably the voltage-sensors and are characterized by a series of positively charged amino acids at every third position.
  • Post-translational
    modifications

    Ubiquitinated by NEDD4L; which promotes its endocytosis. Does not seem to be ubiquitinated by NEDD4 or WWP2.
  • Cellular localization

    Membrane.
  • Target information above from: UniProt accession Q14524 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links

    • Entrez Gene: 6331 Human
    • Entrez Gene: 25665 Rat
    • Omim: 600163 Human
    • SwissProt: Q14524 Human
    • SwissProt: P15389 Rat
    • Unigene: 517898 Human
    • Unigene: 32074 Rat
    • Alternative names

      • Cardiac tetrodotoxin insensitive voltage dependent sodium channel alpha subunit antibody
      • CDCD2 antibody
      • CMD1E antibody
      • CMPD2 antibody
      • HB1 antibody
      • HB2 antibody
      • HBBD antibody
      • HH1 antibody
      • ICCD antibody
      • IVF antibody
      • LQT3 antibody
      • PFHB1 antibody
      • Scn5a (gene name) antibody
      • Scn5a antibody
      • SCN5A_HUMAN antibody
      • Sodium channel protein cardiac muscle alpha subunit antibody
      • Sodium channel protein cardiac muscle subunit alpha antibody
      • Sodium channel protein type 5 subunit alpha antibody
      • Sodium channel protein type V alpha subunit antibody
      • Sodium channel protein type V subunit alpha antibody
      • SSS1 antibody
      • VF1 antibody
      • Voltage gated sodium channel alpha subunit Nav1.5 antibody
      • Voltage-gated sodium channel subunit alpha Nav1.5 antibody
      see all

    Images

    • Western blot - Anti-Nav1.5/SCN5A antibody (ab86321)
      Western blot - Anti-Nav1.5/SCN5A antibody (ab86321)
      All lanes : Anti-Nav1.5/SCN5A antibody (ab86321) at 1 µg/ml

      Lane 1 : Human heart tissue lysate - total protein (ab29431)
      Lane 2 : Heart (Rat) Tissue Lysate

      Lysates/proteins at 10 µg per lane.

      Secondary
      All lanes : Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

      Developed using the ECL technique.

      Performed under reducing conditions.

      Predicted band size: 227 kDa
      Observed band size: 248 kDa
      why is the actual band size different from the predicted?
      Additional bands at: 275 kDa, 41 kDa. We are unsure as to the identity of these extra bands.


      Exposure time: 3 minutes


      Human Sodium channel protein type 5 subunit alpha (Nav1.5/SCN5A) contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted.

    Protocols

    • Western blot protocols

    Click here to view the general protocols

    Datasheets and documents

    • Datasheet
  • References (0)

    Publishing research using ab86321? Please let us know so that we can cite the reference in this datasheet.

    ab86321 has not yet been referenced specifically in any publications.

    Images

    • Western blot - Anti-Nav1.5/SCN5A antibody (ab86321)
      Western blot - Anti-Nav1.5/SCN5A antibody (ab86321)
      All lanes : Anti-Nav1.5/SCN5A antibody (ab86321) at 1 µg/ml

      Lane 1 : Human heart tissue lysate - total protein (ab29431)
      Lane 2 : Heart (Rat) Tissue Lysate

      Lysates/proteins at 10 µg per lane.

      Secondary
      All lanes : Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

      Developed using the ECL technique.

      Performed under reducing conditions.

      Predicted band size: 227 kDa
      Observed band size: 248 kDa
      why is the actual band size different from the predicted?
      Additional bands at: 275 kDa, 41 kDa. We are unsure as to the identity of these extra bands.


      Exposure time: 3 minutes


      Human Sodium channel protein type 5 subunit alpha (Nav1.5/SCN5A) contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Alternative products to Anti-Nav1.5/SCN5A antibody (ab86321)

    •  
    • Product image

      Anti-Nav1.5/SCN5A antibody (ab39992)

      Applications: ICC/IF, IHC-P

    •  
    • Product image

      Anti-Nav1.5/SCN5A antibody (ab116706)

      Applications: IHC-P

    Clear all

    Recently viewed products

    •  
    • Product image

      Anti-SFT antibody [EPR13000(B)] (ab176561)

    •  
    • Product image

      Anti-PAC-2 antibody [EPR9947(2)] (ab172909)

    •  
    • Product image

      Human EGF ELISA Kit (ab217772)

    •  
    • Product image

      Anti-PSGL-1 antibody [HECA-452] (ab110096)

    •  
    • Product image

      Anti-PCK1/PEPC antibody (ab87340)

    •  
    • Anti-HSV2 antibody [B318M] (ab252717)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.